VisualDx

What is VisualDx and who sells it?

VisualDx is based in Rochester, New York, and was founded in 1999 by Art Papier, MD. Wikipedia also names Lowell Goldsmith, MD as co-founder. The company says it sells to hospitals, individual clinicians, life-sciences companies and public health agencies. Its history page names no owner or investors.

Vendor milestones include the Skinsight patient app in 2006, an iPhone app in 2008, HL7 infobutton and SMART on FHIR support in 2012, DermExpert AI for iOS in 2017 and an API in 2021.

What does it do?

The clinician enters findings and patient context, and the builder ranks possible diagnoses. Condition pages list look-alikes, epidemiology and treatment. The homepage puts the library at more than 50,000 clinical images across skin tones and body sites, and the pricing page lists a skin-of-colour atlas as a strength. Images can be compared by skin tone. The pricing page also lists 400-plus patient handouts in English and Spanish, quizzes, CME credit for searches and guided workups.

VisualDx AI analyses images and sits inside paid plans. The homepage also mentions a Perplexity partnership and grounding of language-model answers in VisualDx content. No accuracy data accompany either.

Does it integrate and is it regulated?

The homepage promises EHR integration, single sign-on and API access with "major EHRs", but names none. HIPAA-compliant workflows and security documentation are available on request. The company lists no SOC 2 or HITRUST attestation.

A 2020 DermExpert FAQ says the product is not FDA approved and that VisualDx is exempt from FDA regulation. No FDA clearance is claimed for VisualDx AI.

What does the evidence say?

No peer-reviewed study evaluates VisualDx. The five papers tagged to it concern clinical decision support in general. They include a 2025 Oxford Open Digital Health report on implementing a decision support system in Botswana (PMID 41050646) and a 2023 JMIR Formative Research paper on a mobile decision support system in a resource-limited country (PMID 37815861), and neither is a test of VisualDx. A 2025 World Journal of Methodology paper on an "Electronic Pediatrician" prototype (PMID 40881228) is unrelated.

One paper gives context for the image library. A 2022 Rheumatology study (PMID 34718435) found racial disparities in how skin tones were represented in images of dermatomyositis rashes, which is the gap VisualDx's skin-of-colour coverage targets. The homepage statistics (a 55-day dermatologist wait, 40% unnecessary referrals) come from the vendor.

How much does VisualDx cost?

Core, the education plan, is billed annually at $249.99. Elite, for clinicians, is billed annually at $299.99 (visualdx.com/pricing, as of October 2026). The page shows a free trial of unstated length. If you cancel, there is no refund for the current period, but annual plans that auto-renew have a 30-day grace window for a full refund of the renewal. Small groups of two to five and large groups are quote only.

How does it compare?

DynaMed, UpToDate and Isabel DDx are the common alternatives for diagnosis support. VisualDx's edge is the matched-image comparison, so a physician who mostly needs a drug or guideline lookup is better served elsewhere.

The verdict

A clinician who sees skin findings weekly can test the $299.99 Elite plan on their own cases during the free trial. Do not buy it for the AI image feature until the vendor publishes data on it.